Stay updated on RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma
Sign up to get notified when there's something new on the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page.

Latest updates to the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page metadata. This change updates version information without altering study content or user-facing features.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page revision label was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.2 was added; outdated notices including a government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedNotice about a lapse in government funding is shown, and the site revision has been updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check65 days agoChange DetectedThe update introduces a 'Show glossary' option, adds a new label 'Last Update Submitted that Met QC Criteria', standardizes capitalization for 'No FEAR Act Data', and updates the revision to v3.4.0, while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page; this appears to be an administrative/template change with no impact on trial details.SummaryDifference0.1%

Stay in the know with updates to RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma
Enter your email address, and we'll notify you when there's something new on the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page.